← All stocks

Atea Pharmaceuticals, Inc.

AVIR Net buying

CIK 0001593899 #3209 in the set updated 21 Sep 2026

Bought (120 mo)

$13.21M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.03M

$457.00K on a plan · $0.00 straight out of an exercise

Sold at will

$1.57M

9 of 14 sales

Net

+$11.18M

+$11.64M against sales at will

By person

16 insiders · 24 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hack Andrew A. F.

Director

$6.00M (1)

—

+$6.00M

5,615,659

7.00%

$23.43M

—

Rock Springs Capital Management LP entity

10% owner

$6.00M (2)

—

+$6.00M

289,695

0.3612%

$1.21M

—

Sommadossi Jean-Pierre

President, CEO, and Chairman

—

$457.00K (5) scheduled

−$457.00K

12,558,855

15.66%

$52.39M

+13.1%

BERGER FRANKLIN M

Director

$1.08M (3)

$1.24M (3)

−$156.68K

536,097

0.6684%

$2.24M

+679.8%

Murphy Polly A.

Director

$128.24K (2)

—

+$128.24K

133,040

0.1659%

$554.98K

+1,078%

Polsky Bruce

Director

—

$61.14K (1)

−$61.14K

124,806

0.1556%

$520.63K

+149.6%

Horga Maria Arantxa

Chief Medical Officer

—

$60.96K (1)

−$60.96K

96,086

0.1198%

$400.82K

—

Corcoran Andrea

See Remarks

—

$60.91K (1)

−$60.91K

823,576

1.03%

$3.44M

+57.0%

Hammond Janet MJ

Chief Development Officer

—

$53.91K (1)

−$53.91K

127,665

0.1592%

$532.55K

+1,707%

Foster Wayne

EVP, Chief Accounting Officer

—

$47.90K (1)

−$47.90K

79,329

0.0989%

$330.92K

—

Vavricka John

Chief Commercial Officer

—

$45.42K (1)

−$45.42K

165,102

0.2059%

$688.72K

—

Cormorant Asset Management, LP entity

Former 10% Owner

—

6,411,355

7.99%

$26.74M

—

Chu Chung K.

10% owner

—

1,176,862

1.47%

$4.91M

+17.7%

Lucidi Bruno

Director

—

142,350

0.1775%

$593.81K

+184.7%

DUNCAN BARBARA GAYLE

Director

—

92,350

0.1151%

$385.24K

—

Adams Jerome M.

Director

—

92,350

0.1151%

$385.24K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 106

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 0

Sales at will 9

Transactions with no price 0

Shares from compensation/vesting 18,047,437

Sales filed before the plan box existed 2

History held since 30 Oct 2020